Long‐term follow‐up after <scp>R‐High CHOP</scp>/<scp>CHASER</scp>/<scp>LEED</scp> with <scp>Auto‐PBSCT</scp> in untreated mantle cell lymphoma—Final analysis of <scp>JCOG0406</scp>-Reference-Cited by-同舟云学术

Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406

Published:2023-05-26 Issue:8 Volume:114 Page:3461-3465
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Ogura Michinori¹²,Yamamoto Kazuhito³^ORCID,Morishima Yasuo³,Wakabayashi Masashi⁴,Tobinai Kensei⁵,Ando Kiyoshi⁶,Uike Naokuni⁷,Kurosawa Mitsutoshi⁸,Gomyo Hiroshi⁹,Taniwaki Masafumi¹⁰,Nosaka Kisato¹¹^ORCID,Tsukamoto Norifumi¹²,Shimoyama Tatsu¹³,Fukuhara Noriko¹⁴,Yakushijin Yoshihiro¹⁵^ORCID,Ohnishi Kazunori¹⁶,Miyazaki Kana¹⁷^ORCID,Kameoka Yoshihiro¹⁸,Takayama Nobuyuki¹⁹,Hanamura Ichiro²⁰^ORCID,Kobayashi Hirofumi²¹,Usuki Kensuke²²^ORCID,Kobayashi Naoki²³,Ohyashiki Kazuma²⁴,Utsumi Takahiko²⁵,Kumagai Kyoya²⁶,Maruyama Dai⁵^ORCID,Ohmachi Ken⁶^ORCID,Matsuno Yoshihiro²⁷,Nakamura Shigeo²⁸,Hotta Tomomitsu²⁹,Tsukasaki Kunihiro³⁰,Nagai Hirokazu³¹

Affiliation:

1. Department of Hematology Aichi Sannomaru Clinic Nagoya Japan

2. Department of Hematology and Oncology Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Nagoya Japan

3. Department of Hematology and Cell Therapy Aichi Cancer Center Nagoya Japan

4. JCOG Data Center National Cancer Center Hospital Tokyo Japan

5. Department of Hematology National Cancer Center Hospital Tokyo Japan

6. Department of Hematology and Oncology Tokai University School of Medicine Isehara Japan

7. Department of Hematology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

8. Department of Hematology National Hospital Organization Hokkaido Cancer Center Sapporo Japan

9. Department of Hematology Hyogo Cancer Center Akashi Japan

10. Department of Hematology Kyoto Prefectural University of Medicine Kyoto Japan

11. Department of Hematology Kumamoto University School of Medicine Kumamoto Japan

12. Department of Hematology Gunma University Hospital Maebashi Japan

13. Department of Medical Oncology Tokyo Metropolitan Cancer and Infectious Diseases Center Tokyo Japan

14. Department of Hematology Tohoku University Hospital Sendai Japan

15. First Department of Internal Medicine Ehime University Graduate School of Medicine Tohon‐shi Japan

16. Department of Hematology Hamamatsu University School of Medicine Hamamatsu Japan

17. Department of Hematology and Oncology Mie University Graduate School of Medicine Tsu Japan

18. Department of Hematology, Nephrology, and Rheumatology Akita University Graduate School of Medicine Akita Japan

19. Second Department of Internal Medicine Kyorin University School of Medicine Mitaka Japan

20. Division of Hematology, Department of Internal Medicine Aichi Medical University Nagakute Japan

21. Department of Hematology Saitama Cancer Center Hospital Saitama Japan

22. Department of Hematology NTT Medical Center Tokyo Tokyo Japan

23. Department of Hematology Sapporo Hokuyu Hospital Sapporo Japan

24. Department of Hematology Tokyo Medical University Tokyo Japan

25. Department of Hematology Shiga General Hospital Moriyama Japan

26. Department of Hematology Chiba Cancer Center Chiba Japan

27. Department of Surgical Pathology Hokkaido University Hospital Sapporo Japan

28. Department of Pathology and Clinical Laboratories Nagoya University Hospital Nagoya Japan

29. National Hospital Organization Nagoya Medical Center Nagoya Japan

30. Department of Hematology National Cancer Center East Kashiwa Japan

31. Department of Hematology National Hospital Organization Nagoya Medical Center Nagoya Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15849

Reference8 articles.

1. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. R‐High‐ CHOP / CHASER / LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY

3. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

4. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

5. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur